Action Tendencies and Prognosis in Major Depressive Disorder
Measuring Self-blame-related Action Tendencies and Prediction of Prognosis in Major Depressive Disorder
1 other identifier
observational
140
1 country
1
Brief Summary
Predicting the prognosis and treatment responses in individuals with major depressive disorder (MDD) is currently based on trial and error, because some treatments work for some individuals, but not others. Novel predictors of prognosis and treatment response in MDD can add value to the development of targeted treatments and the stratified approaches to improve long-term outcomes of individuals with MDD. This study uses a novel virtual-reality-based measure of blame-related action tendencies and combines this with established predictors of treatment response and prognosis in individuals with MDD.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jun 2020
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2020
CompletedFirst Submitted
Initial submission to the registry
October 13, 2020
CompletedFirst Posted
Study publicly available on registry
October 20, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2021
CompletedFebruary 28, 2022
September 1, 2020
1 year
October 13, 2020
February 25, 2022
Conditions
Outcome Measures
Primary Outcomes (1)
Self-rated Quick Inventory of Depressive Symptomatology -16
Depressive symptoms assessed by the self-rated Quick Inventory of Depressive Symptomatology sum score. The score ranges from 0 to 27, with a higher score indicating more severe depressive symptoms.
Four months
Secondary Outcomes (2)
General Anxiety Disorder-7
Four months
Maudsley-Modified Patient Health Questionniare -9
Four months
Study Arms (2)
MDD group
Participants with current major depressive disorder (MDD)
Control group
Participants without a family and personal history of a mood disorder, schizophrenia or substance/alcohol abuse but other disorders often co-morbid with MDD are allowed such as anxiety disorders
Interventions
This is an observational study, no intervention is involved
Eligibility Criteria
Potential participants will be identified via online advertisements on Facebook, Google, Twitter, Instagram, self-help web groups, as well as by the IoPPN recruitment circular. Some of participants may also take part in other studies carried out by the same research team (Antidepressant Advisor studies 2 and 3) which recruit patients via online advertisements.
You may qualify if:
- Age≥18
- At least moderately severe major depressive syndrome on PHQ-9 (score≥15) at pre-screening despite having tried a serotonergic antidepressant medication
- Resident in the UK
- Able to complete self-report scales orally or in writing.
- Age≥18
- PHQ scores \< 10 at pre-screening
- Resident in the UK
- Able to complete self-report scales orally or in writing
You may not qualify if:
- Inability to consent to the study
- Unstable medical condition
- Currently being treated by mental health specialist
- Past diagnosis or family history of schizophrenia or schizo-affective disorder
- Current or family history of psychotic symptoms or bipolar disorder.
- Drug or alcohol abuse over the last 6 months, suspected central neurological condition (e.g. dementia, stroke)
- (planned)Pregnancy
- Breastfeeding or within 6 months of giving birth
- Inability to consent to the study
- Past history of MDD
- First-degree family history of MDD
- Unstable medical condition
- Currently being treated by mental health specialist
- Past diagnosis or family history of schizophrenia or schizo-affective disorder
- Current or family history of psychotic symptoms or bipolar disorder.
- +4 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- King's College Londonlead
- Scients Institute, USAcollaborator
Study Sites (1)
King's College London, IoPPN
London, SE5 8AF, United Kingdom
Related Publications (8)
Abramson LY, Seligman ME, Teasdale JD. Learned helplessness in humans: critique and reformulation. J Abnorm Psychol. 1978 Feb;87(1):49-74. No abstract available.
PMID: 649856BACKGROUNDCarver CS. You want to measure coping but your protocol's too long: consider the brief COPE. Int J Behav Med. 1997;4(1):92-100. doi: 10.1207/s15327558ijbm0401_6.
PMID: 16250744BACKGROUNDChekroud AM, Zotti RJ, Shehzad Z, Gueorguieva R, Johnson MK, Trivedi MH, Cannon TD, Krystal JH, Corlett PR. Cross-trial prediction of treatment outcome in depression: a machine learning approach. Lancet Psychiatry. 2016 Mar;3(3):243-50. doi: 10.1016/S2215-0366(15)00471-X. Epub 2016 Jan 21.
PMID: 26803397BACKGROUNDGreen S, Lambon Ralph MA, Moll J, Deakin JF, Zahn R. Guilt-selective functional disconnection of anterior temporal and subgenual cortices in major depressive disorder. Arch Gen Psychiatry. 2012 Oct;69(10):1014-21. doi: 10.1001/archgenpsychiatry.2012.135.
PMID: 22638494BACKGROUNDGreen S, Moll J, Deakin JF, Hulleman J, Zahn R. Proneness to decreased negative emotions in major depressive disorder when blaming others rather than oneself. Psychopathology. 2013;46(1):34-44. doi: 10.1159/000338632. Epub 2012 Aug 7.
PMID: 22890331BACKGROUNDPulcu E, Zahn R, Elliott R. The role of self-blaming moral emotions in major depression and their impact on social-economical decision making. Front Psychol. 2013 Jun 3;4:310. doi: 10.3389/fpsyg.2013.00310. eCollection 2013.
PMID: 23750148BACKGROUNDTangney JP, Stuewig J, Mashek DJ. Moral emotions and moral behavior. Annu Rev Psychol. 2007;58:345-72. doi: 10.1146/annurev.psych.56.091103.070145.
PMID: 16953797BACKGROUNDZahn R, Lythe KE, Gethin JA, Green S, Deakin JF, Workman C, Moll J. Negative emotions towards others are diminished in remitted major depression. Eur Psychiatry. 2015 Jun;30(4):448-53. doi: 10.1016/j.eurpsy.2015.02.005. Epub 2015 Mar 6.
PMID: 25752724BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 13, 2020
First Posted
October 20, 2020
Study Start
June 1, 2020
Primary Completion
June 1, 2021
Study Completion
June 1, 2021
Last Updated
February 28, 2022
Record last verified: 2020-09